RetinalGenix Technologies (RTGN) Receivables - Other (2020 - 2023)
RetinalGenix Technologies (RTGN) reported Receivables - Other of $622806.0 for Q1 2023, up 76.22% on a YoY basis from $353432.0 in Q1 2022, and up 45.54% sequentially from $427933.0 in Q4 2022.
RetinalGenix Technologies (RTGN) Receivables - Other (2020 - 2023) Analysis & Trends
RetinalGenix Technologies (RTGN) has 4 years of Receivables - Other data on file, last reported at $622806.0 in Q1 2023.
- For the quarter ending Q1 2023, Receivables - Other rose 76.22% year-over-year to $622806.0; the trailing twelve-month figure through Mar 2023 stood at $622806.0 (up 76.22% YoY), and the FY2022 full-year result was $427933.0, up 199.84% from the prior year.
- Receivables - Other climbed to $622806.0 in Q1 2023, from $427933.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $622806.0 in Q1 2023 to a low of $15069.0 in Q4 2020.
- A 4-year average of $312392.2 and a median of $353432.0 in 2022 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other soared 847.12% in 2021 and soared 76.22% in 2023, its largest moves.
- Tracing RTGN's Receivables - Other over 4 years: stood at $15069.0 in 2020, then soared by 847.12% to $142721.0 in 2021, then soared by 199.84% to $427933.0 in 2022, then jumped by 45.54% to $622806.0 in 2023.
- Business Quant data shows RTGN's Receivables - Other at $622806.0 in Q1 2023, $427933.0 in Q4 2022, and $353432.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 622,806.00 |
| Mar 31, 2023 | 622,806.00 |
| Dec 31, 2022 | 427,933.00 |
| Dec 31, 2022 | 427,933.00 |
| Mar 31, 2022 | 353,432.00 |
| Mar 31, 2022 | 353,432.00 |
| Dec 31, 2021 | 142,721.00 |
| Dec 31, 2021 | 142,721.00 |
| Dec 31, 2020 | 15,069.00 |
| Dec 31, 2020 | 15,069.00 |